Sihuan Pharmaceutical Holdings Group Ltd (SHPHF)
0.0575
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Sihuan Pharmaceutical Holdings Group Debt to Equity Ratio: 0.2739 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.2739 |
June 30, 2023 | 0.2902 |
December 31, 2022 | 0.26 |
June 30, 2022 | 0.1543 |
December 31, 2021 | 0.1261 |
June 30, 2021 | 0.0825 |
December 31, 2020 | 0.0817 |
June 30, 2020 | 0.0682 |
December 31, 2019 | 0.0009 |
June 30, 2019 | 0.0001 |
December 31, 2018 | 0.0123 |
June 30, 2018 | 0.0226 |
December 31, 2017 | 0.0163 |
June 30, 2017 | 0.0125 |
Date | Value |
---|---|
December 31, 2016 | 0.0061 |
June 30, 2016 | 0.0053 |
December 31, 2015 | 0.0012 |
June 30, 2015 | 0.0011 |
December 31, 2014 | 0.0025 |
June 30, 2014 | 0.00 |
December 31, 2013 | 0.0287 |
June 30, 2013 | 0.0717 |
December 31, 2012 | 0.1091 |
June 30, 2012 | 0.0728 |
December 31, 2011 | 0.0008 |
June 30, 2011 | 0.00 |
December 31, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0001
Minimum
Jun 2019
0.2902
Maximum
Jun 2023
0.1338
Average
0.1043
Median
Debt to Equity Ratio Benchmarks
Sinovac Biotech Ltd | 0.0292 |
CASI Pharmaceuticals Inc | 0.7819 |
Zai Lab Ltd | 0.00 |
I-MAB | 0.0174 |
Gracell Biotechnologies Inc (DELISTED) | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.627B |
Total Liabilities (Quarterly) | 902.64M |
Shareholders Equity (Quarterly) | 625.25M |
Current Ratio | 1.511 |
Net Debt Paydown Yield | -0.18% |